Arginine test is not reliable for diagnosing cerebellar multiple system atrophy

Annals of Neurology

Volumn 67, Issue 3, 2010, Pages 404-408

  Gardner, Raquel C ^a   Schmahmann, Jeremy D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GROWTH HORMONE; SERMORELIN;

ADULT; ARTICLE; BRAIN ATROPHY; CEREBELLUM ATROPHY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FAMILY HISTORY; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HEREDITARY ATAXIA; HUMAN; IDIOPATHIC DISEASE; MALE; MODIFIED INTERNATIONAL COOPERATIVE ATAXIA RATING SCALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; PROVOCATION TEST; RATING SCALE; RELIABILITY; SERUM; SHY DRAGER SYNDROME;

ADULT; ARGININE; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; CEREBELLAR ATAXIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 77950527293     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21898     Document Type: Article

References (20)

1. Quinn N. Multiple System Atrophy. In: Marsden CD, Fahn S, eds. Movement Disorders III. London, UK: Butterworth, 1994:262-281.
2. Abele M, Burk K, Schols L, et al. The aetiology of sporadic adult-onset ataxia. Brain 2002;125:961-968.
3. Gilman S, Little R, Johanns J, et al. Evolution of sporadic olivopontocerebellar atrophy into multiple system atrophy. Neurology 2000;55:527-532. (Pubitemid 30647250)
4. Abele M, Minnerop M, Urbach H, et al. Sporadic adult onset ataxia of unknown etiology: a clinical, electrophysiological and imaging study. J Neurol 2007;254:1384-1389. (Pubitemid 350112326)
5. Pellecchia MT, Pivonello R, Salvatore E, et al. Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia. Clin Endocrinol (Oxf) 2005;62:428-433. (Pubitemid 40503369)
6. Pellecchia MT, Longo K, Pivonello R, et al. Multiple system atrophy is distinguished from idiopathic Parkinson's disease by the arginine growth hormone stimulation test. Ann Neurol 2006;60: 611-615.
7. Muller EE, Locatelli V, Cocchi D. Neuroendocrine control of growth hormone secretion. Physiol Rev 1999;79:511-607. (Pubitemid 29210930)
8. Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 1998;19:717-797. (Pubitemid 128506521)
9. Norbiato G, Bevilacqua M, Righini V, et al. Altered vasopressin response to metoclopramide in multiple system atrophy: evidence of a cholinergic defect in the hypothalamus. Acta Neurol Scand 1992;85:299-301.
10. Benarroch EE, Schmeichel AM, Parisi JE. Depletion of mesopontine cholinergic and sparing of raphe neurons in multiple system atrophy. Neurology 2002;59:944-946.
11. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008;71:670-676.
12. Klockgether T, Bürk K, Wüllner U, et al. Risk factors for idiopathic cerebellar ataxia of late onset. J Neurol Sci 1998;160: 171-174. (Pubitemid 28522543)
13. The Parkinson Study Group. Levodopa and the progression of Parkinson's Disease. N Engl J Med 2004;351:2498-2508.
14. Biller BM, Samuels MH, Zagar A, et al. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 2002;87:2067-2079. (Pubitemid 34521490)
15. Schmahmann JD, Gardner RC, MacMore J, Vangel M. Development of a brief ataxia rating scale (BARS) based on a modified form of the ICARS. Mov Disord 2009;24:1820-1828.
16. Corneli G, Di Somma C, Baldelli R, et al. The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur J Endocrinol 2005;153:257-264. (Pubitemid 41174451)
17. Qu XD, Gaw Gonzalo IT, Al Sayed MY, et al. Influence of body mass index and gender on growth hormone (GH) responses to GH-releasing hormone plus arginine and insulin tolerance tests. J Clin Endocrinol Metab 2005;90: 1563-1569.
18. Aimaretti G, Baffoni C, DiVito L, et al. Comparisons among old and new provocative tests of GH secretion in 178 normal adults. Eur J Endocrinol 2000;142:347-352. (Pubitemid 30230759)
19. Hauser TK, Luft A, Skalej M, et al. Visualization and quantification of disease progression in multiple system atrophy. Mov Disord 2006;10:1674-1681.
20. Abdo WF, van de Warrenburg BP, Munneke M, et al. CSF analysis differentiates multiple-system atrophy from idiopathic lateonset cerebellar ataxia. Neurology 2006;67:474-479. (Pubitemid 44214973)